Back to Search
Start Over
Letter: intestinal inflammation, COVID‐19 and gastrointestinal ACE2—exploring RAS inhibitors. Authors' reply.
- Source :
- Alimentary Pharmacology & Therapeutics; Aug2020, Vol. 52 Issue 3, p571-572, 2p
- Publication Year :
- 2020
-
Abstract
- LINKED CONTENT This article is linked to Taxonera et al an Garg et al papers. To view these articles, visit https://doi.org/10.1111/apt.15804 and https://doi.org/10.1111/apt.15814. [ABSTRACT FROM AUTHOR]
- Subjects :
- COVID-19
INFLAMMATION
LETTERS
AUTHORS
Subjects
Details
- Language :
- English
- ISSN :
- 02692813
- Volume :
- 52
- Issue :
- 3
- Database :
- Complementary Index
- Journal :
- Alimentary Pharmacology & Therapeutics
- Publication Type :
- Academic Journal
- Accession number :
- 144543874
- Full Text :
- https://doi.org/10.1111/apt.15893